Sign In or
Join
Email
Password
Log In
Remember Me
Forgot Password?
Forum
Topic
News
Conversation: Sanofi’s BTK inhibitor tolebrutinib shows ‘promising’ long-term MS data
October 13, 2021 9:24 PM BST
PHARMeMED
Post(s)
697
Sanofi’s BTK inhibitor tolebrutinib shows ‘promising’ long-term MS data
https://www.pharmatimes.com/news/sanofis_btk_inhibitor_tolebrutinib_gains_promising_long-term_ms_data_1380733
Sanofi’s BTK inhibitor tolebrutinib shows ‘promising’ long-term MS data - PharmaTimes
Tolebrutinib reduced multiple sclerosis (MS) disease activity as measured by MRI - News - PharmaTimes
Add Reputation
Increase/decrease reputation points for this member
Do you want to add reputation for this member by this post?
Increase one point for this member.
Decrease one point for this member.
Increase/Decrease
or
cancel
Share
October 13, 2021 9:24 PM BST
Sanofi’s BTK inhibitor tolebrutinib shows ‘promising’ long-term MS data
